Thrombospondin-1 (TSP1) is a potent natural inhibitor of angiogenesis. Although TSP1 has been reported to induce endothelial cell apoptosis in vitro and to downregulate neovascularization in vivo, the molecular mechanisms that link these two processes have yet to be established. Here we report that TSP1 mediates endothelial cell apoptosis and inhibits angiogenesis in association with increased expression of Bax, decreased expression of Bcl-2, and processing of caspase-3 into smaller proapoptotic forms. The ability of TSP1 to induce both endothelial cell apoptosis in vitro and to suppress angiogenesis in vivo was blocked by the caspase-3 inhibitor z-DEVD-FMK. TSP1 also attenuated VEGF-mediated Bcl-2 expression in endothelial cells in vitro and angiogenesis in vivo. Furthermore, TSP1 induced endothelial cell apoptosis and inhibited neovascularization in sponge implants in SCID mice. We conclude that TSP1 induces endothelial cell apoptosis and inhibits neovascularization by altering the profile of survival gene expression and activating caspase-3.

Keywords:
Angiogenesis, Neovascularization, Cysteine protease, Caspase-3, TSP1, Bcl-2, Bax
1.
Lawler J: The structural and functional properties of thrombospondin. Blood 1986;67:1197–1209.
2.
Bornstein P: Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin-1. J Cell Biol 1995;130:503–506.
3.
O’Shea KS, Dixit VM: Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 1988;107:2737–2748.
4.
Taraboletti G, Roberts D, Liotta LA, Giavazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J Cell Biol 1990;111:765–772.
5.
Iruela-Arispe ML, Bornstein P, Sage H: Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991;88:5026–5030.
6.
Tolsma SS, Volpert OV, Good DG, Frazier WA, Polverini PJ, Bouck N: Peptides from two separate domains of the matrix protein thrombospondin 1 have anti-angiogenic activity. J Cell Biol 1993;122:497–511.
7.
DiPietro LA, Nebgen DR: Polverini PJ: Modulation of in vitro angiogenesis by genetic manipulation of endothelial cell thrombospondin. J Vasc Res 1994;31:178–185.
8.
Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989;56:345–355.
9.
Sheibani N, Frazier WA: Thrombospondin-1 expression in transformed endothelial cells restores abnormal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 1995;92:6788–6792.
10.
Castle VP, Dixit VM, Polverini PJ: Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH3T3 cells. Lab Invest 1997;77:51–61.
11.
Yue TL, Wang X, Louden CS, Gupta S, Pillarietti K, Gu JL, Hart TK, Lysko PG, Feuerstein GZ: 2-Methoxyestradiol, an endogenous estrogen metabolite, induce apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and fas expression. Mol Pharmacol 1997;51:951–962.
12.
Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O’Reilly M, Folkman J: Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998;95:5579–5583.
13.
Nuñez G, Clarke MF: The Bcl-2 family of proteins: Regulators of cell death and survival. Trends Cell Biol 1994;4:399–403.
14.
Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614–620.
15.
Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M, Reed JC: Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 1997;94:5113–5118.
16.
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997;275:1129–1132.
17.
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37–43.
18.
Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA: Inhibition of interleukin-1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997;94:2007–2012.
19.
Nör JE, Christensen J, Mooney DJ, Polverini PJ: VEGF-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;154:375–384.
20.
Griscelli F, Li H, Bennaceur-Griscelli A, Soria J, Opolon P, Soria C, Perricaudet M, Yeh P, Lu H: Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell profliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 1998;95:6367–6372.
21.
Guo N, Krutzsch HC, Inman JK, Roberts DD: Thrombospondin-1 and type I repeat peptides of thrombospondin-1 specifically induce apoptosis of endothelial cells. Cancer Res 1997;57:1735–1742.
22.
Villaschi S, Nicosia R: Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model. Modulation of angiogenesis and collagen gel contraction. Lab Invest 1994;71:291–299.
23.
Takahashi K, Sawasaki Y, Hata JI, Mukai K, Goto T: Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990;25:265–274.
24.
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493–501.
25.
Mitra RJ, Wrone-Smith T, Simonian P, Foreman KE, Nuñez G, Nickoloff BJ: Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest 1997;76:99–107.
26.
Gong J, Traganos F, Darzynkiewiez Z: A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994;218:314–319.
27.
Thornberry NA: Interleukin-1β converting enzyme. Methods Enzymol 1994;244:615–631.
28.
Lomo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK: Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 1996;56:40–43.
29.
Mooney DJ, Sano K, Kaufmann PM, Majahod K, Scloo B, Vacanti JP, Langer R: Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res 1997;37:413–420.
30.
Prochownik EV, O’Rourke K, Dixit VM: Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule. J Cell Biol 1989;109:843–852.
31.
Thronberry NA, Lazebnik Y: Caspases: Enemies within. Science 1998;281:1312–1316.
32.
Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL: Quantification of angiogenesis in solid tumors: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474–2484.
33.
Polverini PJ: The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995;6:230–247.
34.
Ferrara N: Vascular endothelial growth factor. Eur J Cancer 1996;32A:2413–2422.
35.
Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the anti-apoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998;273:13313–13316.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.